On Friday, Novo Nordisk announced in a company statement that it has once again applied to the US Food and Drug Administration (FDA) for permission to start marketing the weekly diabetes treatment Ozempic in a higher dosage.
In February, the FDA declined to start processing a previous application since the health authority lacked information on factors such as a new production facility before granting the necessary approvals. Instead, the FDA sent a Refusal to File Letter in March.
Already a subscriber? Log in.
Read the whole article
Get 14 days free access.
No credit card required.
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Stallergenes Greer enters partnership to develop device and app
Stallergenes Greer and Aptar Pharma will collaborate to develop a new connected device with a companion app for patients going through treatment with the allergy company's allergen immunotherapy.
Lundbeck chairman demands change: "We can't live with this"
Years of work developing new treatments at Lundbeck has so far come to nothing. This has led chairman Lars Rasmusssen to demand visible results, even though CEO Deborah Dunsire has essentially had to restart development work since she joined the firm in 2018.
Coloplast could win big on Polish reimbursement changes
The Polish Ministry of Health has increased the reimbursement amount for hydrophilic catheters, which Coloplast supplies. The Danish medtech company calls the new scheme a "breakthrough."
Several positive elements in Eli Lilly Q3 report, says analyst
.jpg)
An analyst at Sydbank thinks that Eli Lilly's third quarter report includes a number of positive elements, and emphasizes that this could also be good news for competitor Novo Nordisk.
Eli Lilly upgrades earnings per share guidance
On Tuesday, US-based pharmaceutical firm Eli Lilly has updated elements of its 2021 financial guidance pertaining to earnings per share (non-GAAP), now expecting USD 7.95-8.05 compared to the previous USD 7.8-8.
Clinical Documentation Specialist 
Data Analytics & Visualization Manager 
Principal Statistician / Statistical Project Director 
CMC Product Support Manager 
Clinical Trial Manager 
Associate Director – MedTech Manufacturing 
Senior Director, Global Regulatory Lead 
Senior Training and Learning Expert – Help us build a best-in-class global learning and quality culture 
Jr. Software Developer, Cardiac Applications – Medical Devices, DK 
Key Account Manager – Lab & Diagnostic 
GxP QA Compliance Manager for Quality Assurance 
Regulatory Science Specialist 
KLIFO is looking for a talented and committed Pharmacovigilance Associate based in Denmark 
Global Product Manager 
Nordic Field Sales Manager 
Head of Engineering, Syntese 
QA Specialist wanted